COMMUNIQUÉS West-GlobeNewswire

Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat Procedures

12/09/2017 - 14:00

New Platform to Offer Enhanced Visualization and Increased Efficiency for Surgery of the Sinuses and Skull Base DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the [...]

MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics

12/09/2017 - 13:06

MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics Broad collaboration to develop a targeted Next-Generation Sequencing assay for microbial infections Workflow for native samples integrating MGI [...]

More people treated with once-weekly semaglutide achieved reductions in both glucose and weight vs. comparator treatments

12/09/2017 - 13:02

Lisbon, Portugal, 12 September 2017 - A post-hoc analysis of the SUSTAIN 1-5 trials demonstrated that a greater proportion of adults with type 2 diabetes achieved a clinically meaningful reduction in both HbA 1c and [...]

Fiasp® significantly improved overall blood sugar control in type 1 diabetes long-term

12/09/2017 - 13:00

Lisbon, Portugal, 12 September 2017 - Fiasp ® (fast-acting insulin aspart), the only approved, new-generation, ultra-fast acting 1-3 mealtime insulin, improved overall blood sugar (HbA 1c ) and post-meal sugar ( [...]

Shire Receives FDA Fast Track Designation for SHP607 for the Prevention of Chronic Lung Disease in Extremely Premature Infants

12/09/2017 - 13:00

Shire Receives FDA Fast Track Designation for SHP607 for the Prevention of Chronic Lung Disease in Extremely Premature Infants Cambridge, Mass. - September 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the biotech [...]

NuCana Announces Positive Results of NUC-1031 (Acelarin®) in Advanced Ovarian Cancer at ESMO 2017

12/09/2017 - 13:00

Acelarin combination with carboplatin achieved 96% disease control rate and 39% response rate in patients with recurrent ovarian cancer EDINBURGH, United Kingdom, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NuCana plc, a [...]

AC IMMUNE COMPLETES RECRUITMENT FOR LOW-DOSE COHORT IN WORLD'S FIRST CLINICAL TRIAL FOR ANTI-ABETA VACCINE TARGETING ALZHEIMER'S DISEASE-LIKE CHARACTERISTICS IN INDIVIDUALS WITH DOWN SYNDROME

12/09/2017 - 12:04

AC Immune completes Recruitment for Low-Dose Cohort of Participants in World's First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer's Disease-like Characteristics in Individuals with Down Syndrome Phase 1b [...]

Saniona AB: Saniona presents Tesomet Phase 2 data at the EASD Congress

12/09/2017 - 12:00

PRESS RELEASE September 12, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that the promising data from its Phase 2a study with Tesomet in type 2 diabetes has been selected for two [...]

PCI Biotech: Initial clinical results from Phase I indicate that vaccination with fimaVACC enhances cellular immune responses

12/09/2017 - 08:00

Oslo (Norway), 12 September 2017 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the first immune [...]

Sandoz proposed biosimilar rituximab accepted for review by the FDA

12/09/2017 - 07:15

Rituximab is indicated to treat blood cancers and immunological diseases such as rheumatoid arthritis[1] Sandoz believes the comprehensive data package submitted to the FDA for review confirms that our biosimilar [...]

Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and Israel

12/09/2017 - 07:15

Basel, Switzerland, September 12, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution agreement with Cardiome Pharma Corp [...]

TiGenix strengthens US operations with senior appointments

12/09/2017 - 07:00

PRESS RELEASE TiGenix strengthens US operations with senior appointments - Dr. Gregory Gordon appointed as Head of Medical Department (U.S.) - Annette Valles-Sukkar appointed as Associate Director, Clinical Project [...]

TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs

12/09/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs - Dr. Gregory Gordon sera à la tête du Département Médical (États-Unis). - Annette Valles-Sukkar occupera [...]

Ossur Hf : Transactions in relation to share buyback program

11/09/2017 - 18:00

Announcement from Össur hf. No. 66/2017 Reykjavík, 11 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Sanofi: Disclosure of trading in own shares

11/09/2017 - 18:00

Disclosure of trading in own shares This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Sanofi : Déclaration des transactions sur actions propres

11/09/2017 - 18:00

Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Virbac: résultats du premier semestre en très légère progression

11/09/2017 - 17:45

Virbac : résultats du premier semestre en très légère progression Communiqué diffusé le 11 septembre 2017 CHIFFRES CONSOLIDÉS AU 30 JUIN en millions d'euros 2017 2016 Évolution 2017/2016 Chiffre d'affaires 437,5 430,0 + [...]

Virbac: slight increase in first half results

11/09/2017 - 17:45

Virbac: slight increase in first half results Press release issued on September 11, 2017 CONSOLIDATED DATA AS OF JUNE 30 th in million € 2017 2016 % change 2017/2016 Revenue from ordinary activities 437.5 430.0 +1.8% [...]

Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2017

11/09/2017 - 17:45

Virbac Mise à disposition du rapport financier semestriel au 30 juin 2017 Communiqué diffusé le 11 septembre 2017 La société annonce avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés [...]